Patents by Inventor Francina C. Chahal

Francina C. Chahal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CANCER-ASSOCIATED ANTIGEN RELATED APPLICATIONS
    Publication number: 20150297697
    Abstract: The present invention provides a novel cancer-associated antigen that can be used in the treatment and diagnosis of cancer. Further, the invention provides amino acid and nucleic acid sequence of the novel antigen, binding proteins, and immunoconjugates. The invention also relates to diagnostic and therapeutic methods and kits.
    Type: Application
    Filed: December 18, 2014
    Publication date: October 22, 2015
    Inventors: Francina C. CHAHAL, Glen MACDONALD, Jeannick CIZEAU
  • TUMOR SPECIFIC ANTIBODY
    Publication number: 20150197575
    Abstract: The present invention provides the amino acid and nucleic acid sequences of heavy chain and light chain complementarity determining regions of a tumor specific antibody. In addition, the invention provides tumor-specific antibodies and immunoconjugates comprising the tumor-specific antibody attached to a toxin or label, and methods and uses thereof. The invention also relates to diagnostic methods and kits using the tumor-specific antibodies of the invention.
    Type: Application
    Filed: January 23, 2015
    Publication date: July 16, 2015
    Inventors: Nicholas Ronald GLOVER, Glen Christopher MacDonald, Joycelyn Entwistle, Jeannick Cizeau, Denis Georges Bosc, Francina C. Chahal
  • Antibody conjugates against variant NFKBIB and uses thereof
    Patent number: 8999334
    Abstract: The present application provides the amino acid and nucleic acid sequences of heavy and light chain complementarity determining regions of a cancer specific antibody directed to an epitope of variant Nuclear Factor Kappa-B inhibitor beta (NFKBIB). In addition, the application provides cancer specific antibodies and immunoconjugates comprising the cancer specific antibody attached to a toxin or a label, and methods of uses thereof. The application also relates to diagnostic methods and kits using the cancer specific antibodies herein. Further, the application provides novel cancer-associated epitopes and antigens of variant NFKBIB, and uses thereof.
    Type: Grant
    Filed: March 26, 2013
    Date of Patent: April 7, 2015
    Assignee: Viventia Bio Inc.
    Inventors: Francina C. Chahal, Jeannick Cizeau
  • Tumor specific antibody
    Patent number: 8969540
    Abstract: The present invention provides the amino acid and nucleic acid sequences of heavy chain and light chain complementarity determining regions of a tumor specific antibody. In addition, the invention provides tumor-specific antibodies and immunoconjugates comprising the tumor-specific antibody attached to a toxin or label, and methods and uses thereof. The invention also relates to diagnostic methods and kits using the tumor-specific antibodies of the invention.
    Type: Grant
    Filed: January 17, 2013
    Date of Patent: March 3, 2015
    Assignee: Viventia Bio Inc.
    Inventors: Nicholas Ronald Glover, Glen Christopher MacDonald, Joycelyn Entwistle, Jeannick Cizeau, Denis Bosc, Francina C. Chahal
  • Cancer-associated antigen
    Patent number: 8946390
    Abstract: The present invention provides a novel cancer-associated antigen that can be used in the treatment and diagnosis of cancer. Further, the invention provides amino acid and nucleic acid sequence of the novel antigen, binding proteins, and immunoconjugates. The invention also relates to diagnostic and therapeutic methods and kits.
    Type: Grant
    Filed: January 25, 2013
    Date of Patent: February 3, 2015
    Assignee: Viventia Bio Inc.
    Inventors: Francina C. Chahal, Glen MacDonald, Jeannick Cizeau
  • Cancer specific antibody and cell surface proteins
    Patent number: 8697075
    Abstract: The present invention provides the amino acid and nucleic acid sequences of heavy chain and light chain complementarity determining regions of a cancer specific antibody. In addition, the invention provides cancer specific antibodies and immunoconjugates comprising the cancer specific antibody attached to a toxin or label, and methods and uses thereof. The invention also relates to diagnostic methods and kits using the cancer specific antibodies of the invention. Further, the invention provides a novel cancer-associated antigen and its uses thereof.
    Type: Grant
    Filed: November 16, 2011
    Date of Patent: April 15, 2014
    Assignee: Viventia Bio Inc.
    Inventors: Nicholas Ronald Glover, Glen Christopher MacDonald, Joycelyn Entwistle, Jeannick Cizeau, Francina C. Chahal
  • ANTIBODY CONJUGATES AGAINST VARIANT NFKBIB AND USES THEREOF
    Publication number: 20130344076
    Abstract: The present application provides the amino acid and nucleic acid sequences of heavy and light chain complementarity determining regions of a cancer specific antibody directed to an epitope of variant Nuclear Factor Kappa-B inhibitor beta (NFKBIB). In addition, the application provides cancer specific antibodies and immunoconjugates comprising the cancer specific antibody attached to a toxin or a label, and methods of uses thereof. The application also relates to diagnostic methods and kits using the cancer specific antibodies herein. Further, the application provides novel cancer-associated epitopes and antigens of variant NFKBIB, and uses thereof.
    Type: Application
    Filed: March 26, 2013
    Publication date: December 26, 2013
    Applicant: Viventia Bio Inc.
    Inventors: Francina C. CHAHAL, Jeannick CIZEAU
  • NOVEL CANCER-ASSOCIATED ANTIGEN
    Publication number: 20130243799
    Abstract: The present invention provides a novel cancer-associated antigen that can be used in the treatment and diagnosis of cancer. Further, the invention provides amino acid and nucleic acid sequence of the novel antigen, binding proteins, and immunoconjugates. The invention also relates to diagnostic and therapeutic methods and kits.
    Type: Application
    Filed: January 25, 2013
    Publication date: September 19, 2013
    Applicant: VIVENTIA BIOTECHNOLOGIES INC.
    Inventors: Francina C. CHAHAL, Glen MACDONALD, Jeannick CIZEAU
  • Tumor Specific Antibody
    Publication number: 20130217865
    Abstract: The present invention provides the amino acid and nucleic acid sequences of heavy chain and light chain complementarity determining regions of a tumor specific antibody. In addition, the invention provides tumor-specific antibodies and immunoconjugates comprising the tumor-specific antibody attached to a toxin or label, and methods and uses thereof. The invention also relates to diagnostic methods and kits using the tumor-specific antibodies of the invention.
    Type: Application
    Filed: January 17, 2013
    Publication date: August 22, 2013
    Applicant: Viventia Biotechnologies Inc.
    Inventors: Nicholas Ronald Glover, Glen Christopher MacDonald, Joycelyn Entwistle, Jeannick Cizeau, Denis Bosc, Francina C. Chahal
  • Antibodies against a cancer-associated epitope of variant NFKBIB and uses thereof
    Patent number: 8426561
    Abstract: The present application provides the amino acid and nucleic acid sequences of heavy and light chain complementarity determining regions of a cancer specific antibody directed to an epitope of variant Nuclear Factor Kappa-B inhibitor beta (NFKBIB). In addition, the application provides cancer specific antibodies and immunoconjugates comprising the cancer specific antibody attached to a toxin or a label, and methods of uses thereof. The application also relates to diagnostic methods and kits using the cancer specific antibodies herein. Further, the application provides novel cancer-associated epitopes and antigens of variant NFKBIB, and uses thereof.
    Type: Grant
    Filed: November 27, 2008
    Date of Patent: April 23, 2013
    Inventors: Francina C. Chahal, Jeannick Cizeau
  • Cancer-associated antigen
    Patent number: 8389286
    Abstract: The present invention provides a novel cancer-associated antigen that can be used in the treatment and diagnosis of cancer. Further, the invention provides amino acid and nucleic acid sequence of the novel antigen, binding proteins, and immunoconjugates. The invention also relates to diagnostic and therapeutic methods and kits.
    Type: Grant
    Filed: April 26, 2011
    Date of Patent: March 5, 2013
    Assignee: Viventia Biotechnologies Inc.
    Inventors: Francina C. Chahal, Glen MacDonald, Jeannick Cizeau
  • CD44E tumor specific antibody
    Patent number: 8383117
    Abstract: The present invention provides the amino acid and nucleic acid sequences of heavy chain and light chain complementarity determining regions of a tumor specific antibody. In addition, the invention provides tumor-specific antibodies and immunoconjugates comprising the tumor-specific antibody attached to a toxin or label, and methods and uses thereof. The invention also relates to diagnostic methods and kits using the tumor-specific antibodies of the invention.
    Type: Grant
    Filed: June 10, 2005
    Date of Patent: February 26, 2013
    Assignee: Viventia Biotechnologies Inc.
    Inventors: Nicholas Ronald Glover, Glen Christopher MacDonald, Joycelyn Entwistle, Jeannick Cizeau, Denis Georges Bosc, Francina C. Chahal
  • Antibodies Against A Cancer-Associated Epitope of Variant HNRNPG and Uses Thereof
    Publication number: 20130039931
    Abstract: The present application provides the amino acid and nucleic acid sequences of heavy chain and light chain complementarity determining regions of a cancer specific antibody. In addition, the application provides cancer specific antibodies and immunoconjugates comprising the cancer specific antibody attached to a toxin or label, and methods and uses thereof. The application also relates to diagnostic methods and kits using the cancer specific antibodies disclosed herein. Further, the application provides novel cancer-associated epitopes and antigens, and uses thereof.
    Type: Application
    Filed: August 22, 2012
    Publication date: February 14, 2013
    Inventors: Jeannick Cizeau, Francina C. Chahal
  • Antibodies against a cancer-associated epitope of variant HnRNPG and uses thereof
    Patent number: 8273550
    Abstract: The present application provides the amino acid and nucleic acid sequences of heavy and light chain complementarity determining regions of a cancer specific antibody directed to an epitope of variant Heterogeneous Ribonucleoprotein G (HnRNPG). In addition, the application provides cancer specific antibodies and immunoconjugates comprising the cancer specific antibody attached to a toxin or label, and methods of uses thereof. The application also relates to diagnostic methods and kits using the cancer specific antibodies disclosed herein. Further, the application provides novel cancer-associated epitopes and antigens of variant HnRNPG, and uses thereof.
    Type: Grant
    Filed: October 23, 2008
    Date of Patent: September 25, 2012
    Assignee: Viventia Biotechnologies Inc.
    Inventors: Jeannick Cizeau, Francina C. Chahal
  • CANCER SPECIFIC ANTIBODY AND CELL SURFACE PROTEINS
    Publication number: 20120128723
    Abstract: The present invention provides the amino acid and nucleic acid sequences of heavy chain and light chain complementarity determining regions of a cancer specific antibody. In addition, the invention provides cancer specific antibodies and immunoconjugates comprising the cancer specific antibody attached to a toxin or label, and methods and uses thereof. The invention also relates to diagnostic methods and kits using the cancer specific antibodies of the invention. Further, the invention provides a novel cancer-associated antigen and its uses thereof.
    Type: Application
    Filed: November 16, 2011
    Publication date: May 24, 2012
    Applicant: VIVENTIA BIOTECHNOLOGIES INC.
    Inventors: Francina C. CHAHAL, Joycelyn ENTWISTLE, Jeannick CIZEAU, Nicholas Ronald GLOVER, Glen Christopher MACDONALD
  • NOVEL CANCER-ASSOCIATED ANTIGEN
    Publication number: 20120058106
    Abstract: The present invention provides a novel cancer-associated antigen that can be used in the treatment and diagnosis of cancer. Further, the invention provides amino acid and nucleic acid sequence of the novel antigen, binding proteins, and immunoconjugates. The invention also relates to diagnostic and therapeutic methods and kits.
    Type: Application
    Filed: April 26, 2011
    Publication date: March 8, 2012
    Applicant: VIVENTIA BIOTECHNOLOGIES INC.
    Inventors: FRANCINA C. CHAHAL, GLEN MACDONALD, JEANNICK CIZEAU
  • Cancer associated glucose transporter 8 variant
    Patent number: 8084576
    Abstract: The present invention provides the amino acid and nucleic acid sequences of heavy chain and light chain complementarity determining regions of a cancer specific antibody. In addition, the invention provides cancer specific antibodies and immunoconjugates comprising the cancer specific antibody attached to a toxin or label, and methods and uses thereof. The invention also relates to diagnostic methods and kits using the cancer specific antibodies of the invention. Further, the invention provides a novel cancer-associated antigen and its uses thereof.
    Type: Grant
    Filed: December 21, 2005
    Date of Patent: December 27, 2011
    Assignee: Viventia Biotechnologies Inc.
    Inventors: Nicholas Ronald Glover, Glen Christopher MacDonald, Joycelyn Entwistle, Jeannick Cizeau, Francina C. Chahal
  • Cancer-associated antigen
    Patent number: 7956162
    Abstract: The present invention provides a novel cancer-associated antigen that can be used in the treatment and diagnosis of cancer. Further, the invention provides amino acid and nucleic acid sequence of the novel antigen, binding proteins, and immuno-conjugates. The invention also relates to diagnostic and therapeutic methods and kits.
    Type: Grant
    Filed: December 21, 2006
    Date of Patent: June 7, 2011
    Assignee: Viventia Biotechnologies Inc.
    Inventors: Francina C. Chahal, Glen MacDonald, Jeannick Cizeau
  • Antibodies Against a Cancer-Associated Epitope of Variant NFKBIB and Uses Thereof
    Publication number: 20100322919
    Abstract: The present application provides the amino acid and nucleic acid sequences of heavy and light chain complementarity determining regions of a cancer specific antibody directed to an epitope of variant Nuclear Factor Kappa-B inhibitor beta (NFKBIB). In addition, the application provides cancer specific antibodies and immunoconjugates comprising the cancer specific antibody attached to a toxin or a label, and methods of uses thereof. The application also relates to diagnostic methods and kits using the cancer specific antibodies herein. Further, the application provides novel cancer-associated epitopes and antigens of variant NFKBIB, and uses thereof.
    Type: Application
    Filed: November 27, 2008
    Publication date: December 23, 2010
    Inventors: Francina C. Chahal, Jeannick Cizeau
  • Antibodies Against a Cancer-Associated Epitope of Variant HNRNPG and Uses Thereof
    Publication number: 20100303814
    Abstract: The present application provides the amino acid and nucleic acid sequences of heavy and light chain complementarity determining regions of a cancer specific antibody directed to an epitope of variant Heterogeneous Ribonucleoprotein G (HnRNPG). In addition, the application provides cancer specific antibodies and immunoconjugates comprising the cancer specific antibody attached to a toxin or label, and methods of uses thereof. The application also relates to diagnostic methods and kits using the cancer specific antibodies disclosed herein. Further, the application provides novel cancer-associated epitopes and antigens of variant HnRNPG, and uses thereof.
    Type: Application
    Filed: October 23, 2008
    Publication date: December 2, 2010
    Inventors: Jeannick Cizeau, Francina C. Chahal